Biodesix, Inc. (BDSX) vs CAMP4 Therapeutics Corporation (CAMP)
A side-by-side comparison of Biodesix, Inc. and CAMP4 Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BDSX
Biodesix, Inc.
$27.98HealthcareDelayed quote: Oct 6, 2026, 3:40 PM EDT
CAMP
CAMP4 Therapeutics Corporation
$3.88HealthcareDelayed quote: Oct 6, 2026, 3:40 PM EDT
Total return — BDSX vs CAMP
growth of $100 · dividends reinvested · last 2yBDSX -14.0% (-7.3%/yr)CAMP -62.6% (-38.8%/yr)BDSX compounded faster over this window
BDSX CAMP
BDSX vs CAMP: by the numbers
- •CAMP is the larger company ($243M vs $228M market cap).
- •Both run net losses; BDSX's is the smaller (-26.97% vs -2543.74% net margin).
- •BDSX grew revenue faster over the past five years (5.99% vs -57.68% CAGR).
Metrics side by side
Valuation
| Metric | BDSX | CAMP |
|---|---|---|
| P/S ratio | 2.21 | 57.75 |
| P/B ratio | 24.91 | N/A |
Profitability
| Metric | BDSX | CAMP |
|---|---|---|
| Gross margin | 82.50% | 53.14% |
| Operating margin | -31.37% | -1488.31% |
| Net margin | -26.97% | -2543.74% |
| ROE | -303.61% | N/A |
| ROIC | -25.73% | -69.76% |
Growth (annualized)
| Metric | BDSX | CAMP |
|---|---|---|
| Revenue CAGR (5Y) | 5.99% | -57.68% |
| Total return CAGR (5Y) | -28.49% | N/A |
Frequently asked
- Which has grown faster, BDSX or CAMP?
- Over the past five years, BDSX grew revenue faster — BDSX at a 5.99% CAGR versus CAMP at -57.68%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.